Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Hale Yapici-Eser, Merve Yalcinay-Inan, Mehmet Utku Kucuker, Can Misel Kilciksiz, Sezen Yilmaz, Neris Dincer, Ozge Kilic, Alaattin Cenk Ercan & Omer Aydemir. (2023) Subjective cognitive assessments and N-back are not correlated, and they are differentially affected by anxiety and depression. Applied Neuropsychology: Adult 30:5, pages 591-601.
Read now
Read now
Luke R. Miller, Ross Divers, Christopher Reed, Erika Pugh & Matthew Calamia. (2023) Resilience as a moderator of depression and anxiety: a bidimensional approach to predictors of subjective cognition in older adults. Aging & Mental Health 27:1, pages 29-34.
Read now
Read now
Tomiki Sumiyoshi, Hiroyuki Uchida, Koichiro Watanabe, Masato Oosawa, Hongye Ren, Yoshiya Moriguchi, Keita Fujikawa & Jovelle Fernandez. (2022) Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder. Neuropsychiatric Disease and Treatment 18, pages 2507-2517.
Read now
Read now
Sergio De Filippis, Anna Pugliese, Michael Cronquist Christensen, Gianluca Rosso, Marco Di Nicola, Kenneth Simonsen & Hongye Ren. (2022) Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice in Italy: Results from the RELIEVE Study. Neuropsychiatric Disease and Treatment 18, pages 1665-1677.
Read now
Read now
Ross Divers, Anthony Robinson, Luke Miller, Alyssa N. De Vito, Erika Pugh & Matthew Calamia. (2022) Beyond depression: examining the role of anxiety and anxiety sensitivity on subjective cognition and functioning in older adults. Aging & Mental Health 26:11, pages 2300-2306.
Read now
Read now
Gang Wang, Kristin Hui Xian Tan, Hongye Ren & Lene Hammer-Helmich. (2020) Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study. Neuropsychiatric Disease and Treatment 16, pages 749-759.
Read now
Read now
Josep Maria Haro, Lene Hammer-Helmich, Delphine Saragoussi, Anders Ettrup & Klaus Groes Larsen. (2019) Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study. Neuropsychiatric Disease and Treatment 15, pages 2313-2323.
Read now
Read now
Articles from other publishers (30)
Navaldeep Kaur, Sorayya Askari, Lesley K. Fellows, Marie-Josée Brouillette & Nancy E. Mayo. (2022) Development of a self-report measure of cognitive change: assessment of interpretability in two samples, people with HIV and people without HIV. Quality of Life Research 32:3, pages 853-865.
Crossref
Crossref
Joanna K. Szmyd, Karol Lewczuk, Kayla M. Teopiz, Roger S. McIntyre & Adam Wichniak. (2023) THINC-Integrated Tool (THINC-it): A Brief Measurement of Changes in Cognitive Functioning and Its Correlation with the Life Quality of Patients with Schizophrenia and Related Disorders—A Pilot Study. Brain Sciences 13:3, pages 389.
Crossref
Crossref
Danmei He, Minlan Yuan, Wen Dang, Lin Bai, Runnan Yang, Jingyi Wang, Yao Ma, Bo Liu, Shiyu Liu, Simai Zhang, Xiao Liao & Wei Zhang. (2023) Long term neuropsychiatric consequences in COVID-19 survivors: Cognitive impairment and inflammatory underpinnings fifteen months after discharge. Asian Journal of Psychiatry 80, pages 103409.
Crossref
Crossref
Ying-Jay Liou, Mu-Hong Chen, Ju-Wei Hsu, Kai-Lin Huang, Po-Hsun Huang & Ya-Mei Bai. (2022) Circulating endothelial progenitor cell dysfunction in patients with bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience.
Crossref
Crossref
Jennifer L Phillips, Amanda Van Geel, Patricia Burhunduli, Dominique Vasudev, Lisa A Batten, Sandhaya Norris, Jeanne Talbot, Abigail Ortiz, Olabisi Owoeye & Pierre Blier. (2022) Assessment of Objective and Subjective Cognitive Function in Patients With Treatment-Resistant Depression Undergoing Repeated Ketamine Infusions. International Journal of Neuropsychopharmacology 25:12, pages 992-1002.
Crossref
Crossref
Faith Matcham, Daniel Leightley, Sara Siddi, Femke Lamers, Katie M. White, Peter Annas, Giovanni de Girolamo, Sonia Difrancesco, Josep Maria Haro, Melany Horsfall, Alina Ivan, Grace Lavelle, Qingqin Li, Federica Lombardini, David C. Mohr, Vaibhav A. Narayan, Carolin Oetzmann, Brenda W. J. H. Penninx, Stuart Bruce, Raluca Nica, Sara K. Simblett, Til Wykes, Jens Christian Brasen, Inez Myin-Germeys, Aki Rintala, Pauline Conde, Richard J. B. Dobson, Amos A. Folarin, Callum Stewart, Yatharth Ranjan, Zulqarnain Rashid, Nick Cummins, Nikolay V. Manyakov, Srinivasan Vairavan & Matthew Hotopf. (2022) Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD): recruitment, retention, and data availability in a longitudinal remote measurement study. BMC Psychiatry 22:1.
Crossref
Crossref
Christina M. van der Feltz-Cornelis, Jennifer Sweetman, Gail Allsopp, Emily Attree, Michael G. Crooks, Daniel J. Cuthbertson, Denise Forshaw, Mark Gabbay, Angela Green, Melissa Heightman, Toby Hillman, Lyth Hishmeh, Kamlesh Khunti, Gregory Y. H. Lip, Paula Lorgelly, Hugh Montgomery, W. David Strain, Emma Wall, Caroline Watkins, Nefyn Williams, Dan G. Wootton & Amitava Banerjee. (2022) STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol. PLOS ONE 17:11, pages e0277936.
Crossref
Crossref
Maggie McCue, Christopher Blair, Ben Fehnert, James King, Francesca Cormack, Sara Sarkey, Anna Eramo, Christopher Kabir, Rasha Khatib & David Kemp. (2022) Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study. JMIR Formative Research 6:10, pages e34923.
Crossref
Crossref
Koichiro Watanabe, Tatsuro Marumoto, Holly Ge, Yoshiya Moriguchi, Keita Fujikawa & Jovelle L. Fernandez. (2022) Association between baseline cognitive symptoms and the subsequent presenteeism and global function in patients with major depressive disorder. Journal of Psychiatric Research 154, pages 324-331.
Crossref
Crossref
E. Papalexi, A. Galanopoulos, D. Roukas, I. Argyropoulos, I. Michopoulos, A. Douzenis, I. Gkolia, P. Fotiadis, D. Kontis & I.M. Zervas. (2022) Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD). Journal of Affective Disorders 314, pages 185-192.
Crossref
Crossref
Eugenia Papalexi, Andreas Galanopoulos, Dimitrios Kontis, Maria Markopoulou, Georgia Balta, Evaggelos Karavelas, Panagiotis Panagiotidis, Themistoklis Vlachos & Anders Ettrup. (2022) Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects. BMC Psychiatry 22:1.
Crossref
Crossref
Mehmet Inceer, Marie‐J. Brouillette, Lesley K. Fellows, José A. Morais, Marianne Harris, Fiona Smaill, Graham Smith, Réjean Thomas & Nancy E. Mayo. (2022) Factors partitioning physical frailty in people aging with HIV: A classification and regression tree approach. HIV Medicine 23:7, pages 738-749.
Crossref
Crossref
Shinichi Noto, Mayumi Wake, Izumi Mishiro, Lene Hammer-Helmich, Hongye Ren, Yoshiya Moriguchi, Keita Fujikawa & Jovelle Fernandez. (2022) Health-Related Quality of Life Over 6 Months in Patients With Major Depressive Disorder Who Started Antidepressant Monotherapy. Value in Health Regional Issues 30, pages 127-133.
Crossref
Crossref
Ying‐Jay Liou, Mu‐Hong Chen, Ju‐Wei Hsu, Kai‐Lin Huang, Po‐Hsun Huang & Ya‐Mei Bai. (2022) Levels of circulating endothelial progenitor cells inversely correlate with manic and positive symptom severity in patients with bipolar disorder. Brain and Behavior 12:6.
Crossref
Crossref
Valeria de Angel, Serena Lewis, Sara Munir, Faith Matcham, Richard Dobson & Matthew Hotopf. (2022) Using digital health tools for the Remote Assessment of Treatment Prognosis in Depression (RAPID): a study protocol for a feasibility study. BMJ Open 12:5, pages e059258.
Crossref
Crossref
Kelly Allott, Caroline X. Gao, Caroline Fisher, Sarah E Hetrick, Kate M Filia, Jana M Menssink, Helen E Herrman, Debra J Rickwood, Alexandra G Parker, Patrick D McGorry & Sue M Cotton. (2021) The Neuropsychological Symptoms Self‐Report: psychometric properties in an adolescent and young adult mental health cohort. Child and Adolescent Mental Health 27:2, pages 111-121.
Crossref
Crossref
Seung-Hoon Lee, Sang Won Jeon, Cheolmin Shin, Chi-Un Pae, Ashwin A. Patkar, Prakash S. Masand, Hyonggin An & Changsu Han. (2022) Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study. Psychiatry Investigation 19:4, pages 268-280.
Crossref
Crossref
Gregory W. Mattingly, Hongye Ren, Michael Cronquist Christensen, Martin A. Katzman, Mircea Polosan, Kenneth Simonsen & Lene Hammer-Helmich. (2022) Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study. Frontiers in Psychiatry 13.
Crossref
Crossref
Yung-Chieh Yen, Nan-Ying Chiu, Tzung-Jeng Hwang, Tung-Ping Su, Yen-Kuang Yang, Cheng-Sheng Chen, Cheng-Ta Li, Kuan-Pin Su, Te-Jen Lai & Chia-Ming Chang. (2022) A Multi-Center Study for the Development of the Taiwan Cognition Questionnaire (TCQ) in Major Depressive Disorder. Journal of Personalized Medicine 12:3, pages 359.
Crossref
Crossref
Marco Di Nicola, Maria Pepe, Isabella Panaccione, Lorenzo Moccia, Luigi Dattoli, Marzia Molinaro, Gabriele Sani, Luigi Janiri & Roger S. McIntyre. (2020) Effect of vortioxetine in subjects with major depressive and alcohol use disorders: a 6-month retrospective analysis. CNS Spectrums 27:1, pages 73-81.
Crossref
Crossref
Tomiki Sumiyoshi, Tatsuya Hoshino, Izumi Mishiro, Lene Hammer-Helmich, Holly Ge, Yoshiya Moriguchi, Keita Fujikawa & Jovelle L. Fernandez. (2022) Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder. Journal of Affective Disorders 296, pages 95-102.
Crossref
Crossref
Mitra Moazzami, Patricia Katz, Dennisse Bonilla, Lisa Engel, Jiandong Su, Pooneh Akhavan, Nicole Anderson, Oshrat E Tayer-Shifman, Dorcas Beaton & Zahi Touma. (2021) Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematous. Lupus 30:13, pages 2102-2113.
Crossref
Crossref
Ying-Jay Liou, Mu-Hong Chen, Ju-Wei Hsu, Kai-Lin Huang, Po-Hsun Huang & Ya-Mei Bai. (2021) Associations between increased circulating endothelial progenitor cell levels and anxiety/depressive severity, cognitive deficit and function disability among patients with major depressive disorder. Scientific Reports 11:1.
Crossref
Crossref
Cheolmin Shin, Chi-Un Pae, Kyung Phil Kwak, Sang Won Jeon, Hyun-Ghang Jeong, Jong-Woo Kim, Youn Jung Lee, Ashwin A. Patkar & Changsu Han. (2021) Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder. Clinical Psychopharmacology and Neuroscience 19:2, pages 243-253.
Crossref
Crossref
Sorayya Askari, Lesley K. Fellows, Marie-Josée Brouillette & Nancy E. Mayo. (2020) Development and validation of a voice-of-the-patient measure of cognitive concerns experienced by people living with HIV. Quality of Life Research 30:3, pages 921-930.
Crossref
Crossref
Heather Cuevas & Sharon Carter. (2021) Nurse-Talk Ratios as a Measure of Participation in a Cognitive Rehabilitation Intervention for People With Type 2 Diabetes. Research and Theory for Nursing Practice 35:1, pages 67-81.
Crossref
Crossref
Pratap Chokka, Holly Ge, Joanna Bougie, Anders Ettrup & Guerline Clerzius. (2021) Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study. Therapeutic Advances in Psychopharmacology 11, pages 204512532110131.
Crossref
Crossref
Ricardo J O Ferreira, Maarten de Wit, Marta Henriques, Ana F Pinto, Cátia Duarte, Elsa Mateus, Gabriel Mendes, José A P da Silva & Mwidimi Ndosi. (2020) ‘It can’t be zero!’ Difficulties in completing patient global assessment in rheumatoid arthritis: a mixed methods study. Rheumatology 59:5, pages 1137-1147.
Crossref
Crossref
Sonya Dhillon, Grace Videla-Nash, George Foussias, Zindel V. Segal & Konstantine K. Zakzanis. (2020) On the nature of objective and perceived cognitive impairments in depressive symptoms and real-world functioning in young adults. Psychiatry Research 287, pages 112932.
Crossref
Crossref
Francesca Cormack, Maggie McCue, Nick Taptiklis, Caroline Skirrow, Emilie Glazer, Elli Panagopoulos, Tempest A van Schaik, Ben Fehnert, James King & Jennifer H Barnett. (2019) Wearable Technology for High-Frequency Cognitive and Mood Assessment in Major Depressive Disorder: Longitudinal Observational Study. JMIR Mental Health 6:11, pages e12814.
Crossref
Crossref